From Wikipedia, the free encyclopedia
A study from authors at Georgetown University have shown that there is no safety or efficacy benefit to levoleucovorin.
|This article relies largely or entirely on a single source. (February 2015)|
|This pharmacology-related article is a stub. You can help Wikipedia by expanding it.|